The Use of Educational Technology in Improving Adherence Therapy

Summary

Few studies show the benefits of educational technologies a support for the control of chronic diseases. The approach known as 'embracement' adopts relational strategies or soft technologies which promote bonding and may impact therapy adherence and quality of life in hypertensive patients.Objectives:To assess the impact of the embracement approach on therapy adherence, quality of life, and the white coat effect in hypertensive outpatients followed in a specialized clinic. This approach may be associated or not with the use of educational technology in a virtual learning environment(VLE) for distance learning (DL) and with use the educational technology in Blended E-learning (E-BLENDED)

Conditions

• Medication Nonadherence
• Hypertension, Resistant to Conventional Therapy

Interventions

BEHAVIORAL

Experimental: Individual Orientation

This approach may be individual orientation with by an embracement strategy (relational strategies) may be making 7 nursing visits at 20-day intervals, for 4 month.

BEHAVIORAL

Experimental: VLE for Distance Learning

Experimental: This approach may be associated with the use of educational technology (E-Care of Hypertension) in a virtual learning environment(VLE) for distance learning (DL) consultation with the health professional and making 7 nursing visits at 20-day intervals, for 4 months

BEHAVIORAL

Experimental: E-blended Lerarning

This approach may be associated with the use of educational technology (E-Care of Hypertension) in the blended e-learning mode associated with face-to-face with the health professional and making 7 nursing visits at 20-day intervals, for 4 months

OTHER

Conventional Therapy - Control Group

This approach may be individual orientation with conventional therapy may be making 2 nursing visits at baseline and 1 after 120 days,

Sponsors & Collaborators

• Luiz Aparecido Bortolotto

  collaborator UNKNOWN

• Chao Lung Wen

  collaborator UNKNOWN

• Margarida Vieira

  collaborator UNKNOWN

• Miriam Harume Tsunemi

  collaborator UNKNOWN

• Isabela Ribeiro Braga Fistarol

  collaborator UNKNOWN

• Jefferson Carlos de Oliveira

  collaborator UNKNOWN

• Dante Marcelo Artiga Giorgi

  collaborator UNKNOWN

• Heno Ferreira Lopes

  collaborator UNKNOWN

• Fernanda Marciano Consolim-Colombo

  collaborator UNKNOWN

• Ivonete Sanches Giacometti Kowalski

  collaborator UNKNOWN

• University of Sao Paulo General Hospital

  lead OTHER

Study Design

Allocation

NON_RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

TRIPLE

Model

SINGLE_GROUP

Eligibility

Min Age

20 Years

Max Age

65 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2013-12-18

Primary Completion

2015-04-25

Completion

2017-02-17